Strength Seen In Covidien: Stock Soars 20.5% - Tale Of The Tape

Covidien plc COV was a big mover last session with its shares surging over 20% on the day. The positive market sentiment was a result of medical technology giant Medtronic Inc.'s MDT announcement of its plans to acquire Covidien in a deal worth $42.9 billion. The move came on solid volume too with far more shares of Covidien changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $70.65 to $73.60 in the past one-month time frame.

This medical instruments and supplies company has seen no estimate revisions in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.

Covidien currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked Med Product stocks like Cardica Inc. CRDC and ICU Medical, Inc. ICUI are worth a look. Both the stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

COVIDIEN PLC COV: Free Stock Analysis Report

MEDTRONIC MDT: Free Stock Analysis Report

CARDICA INC CRDC: Free Stock Analysis Report

ICU MEDICAL INC ICUI: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs